Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 6 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

No phase data available

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials
NCT05765396Active Not Recruiting

SARS-CoV-2/COVID-19 Study of Next Generation Non-Invasive Passive Detection Technologies

Role: collaborator

NCT06402318Recruiting

Passive Detection- SARS-CoV-2 (COVID-19) A&M Breathalyzer (PROTECT Kiosk) for Operational Medicine

Role: collaborator

NCT05827250Unknown

Vibroacoustic Study of Lung Development in Newborn Infants

Role: lead

NCT05386654Completed

imPulse™ Tor System Self-Directed Cuffless Blood Pressure Monitoring

Role: lead

NCT04941209Completed

imPulse™ Una Infrasound-to-ultrasound E-stethoscope

Role: lead

NCT04556149Completed

imPulse™ Una Full-spectrum, Over Clothing E-stethoscope

Role: lead

All 6 trials loaded